Quantedge Capital’s Oscar Health OSCR Stock Holding History

Quantedge Capital’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-43,200	Closed	-$241K	–	129
2023 Q3	$241K	Buy	43,200 +30,300	+235%	+$212K	0.13%	104
2023 Q2	$104K	Buy	+12,900	New	+$95.1K	0.05%	122

Other funds holding OSCR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Formation8 Los Altos, California $67.6M AUM

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ancient Art Austin, Texas $459M AUM 52.34% 1-Year Est. Return

Quantedge Capital's OSCR Position: Q4 2023 in Review

Quantedge Capital sold out of Oscar Health (OSCR) in Q4 2023, closing a stake of 43,200 shares — an estimated $241K sold.

Quantedge Capital first reported a position in OSCR in Q2 2023 and held it in 2 quarters. The position peaked at $241K in Q3 2023. 188 funds tracked by Wall St. Rank hold OSCR as of Q4 2023.

Quantedge Capital reported no remaining Oscar Health position as of Q4 2023 after selling out during the quarter.
Quantedge Capital sold 43,200 Oscar Health shares in Q4 2023, an estimated $241K.
Quantedge Capital first reported a position in Oscar Health in Q2 2023 and held it in 2 quarters.
Quantedge Capital's Oscar Health position peaked at $241K in Q3 2023.
188 funds tracked by Wall St. Rank held Oscar Health as of Q4 2023.

Based on Quantedge Capital's 13F filing for Q4 2023, filed 13 Feb 2024.